Production (Stage)
ESSA Pharma Inc.
EPIX
$1.67
-$0.03-1.77%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.50M | -31.11M | -28.54M | -27.67M | -27.73M |
| Total Depreciation and Amortization | 92.90K | 91.10K | 90.70K | 95.10K | 102.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.19M | 8.40M | 6.15M | 4.22M | 2.97M |
| Change in Net Operating Assets | -2.22M | 218.50K | -418.80K | -483.40K | 1.66M |
| Cash from Operations | -22.43M | -22.40M | -22.72M | -23.84M | -23.00M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.97M | 79.63M | 91.79M | 70.50M | 69.59M |
| Cash from Investing | 16.97M | 79.63M | 91.79M | 70.50M | 69.59M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -32.10K | -67.60K |
| Issuance of Common Stock | 85.30K | 728.90K | 925.60K | 884.30K | 858.70K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 85.30K | 728.90K | 925.60K | 852.30K | 791.20K |
| Foreign Exchange rate Adjustments | 4.60K | 8.70K | 9.10K | 4.20K | 4.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.37M | 57.97M | 70.01M | 47.52M | 47.38M |